MiGenTra Egypt is the first and largest biotech process R&D and biomanufacturing facility in Egypt, Africa, and the Middle East. The company specializes in the process development and end-to-end manufacturing of therapeutic recombinant proteins with a primary focus on the areas of liver disease, thrombosis and haemostasis, infertility, oncology, as well as rheumatoid arthritis.
The company’s first and foremost goal is to provide patients with highly innovative and affordable genetically engineered recombinant drugs with the highest standard of quality.
MiGenTra Egypt has already developed and is manufacturing 10 therapeutic recombinant proteins.
Company Details
- Employees
- 95
- Address
- Mina Street 3rd Industrial Zone A2, 10th Of Ramadan City - Egypt,egypt
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.migentra-egypt.com/
- Keywords
- Engineer jobs.
- HQ
- 10th of Ramadan City - Egypt
Migentra Egypt Questions
Migentra Egypt's website is http://www.migentra-egypt.com/
Migentra Egypt's LinkedIn profile is https://eg.linkedin.com/company/migentra-egypt
Migentra Egypt has
95 employees.
View email and phone details for 95
employees at Migentra Egypt.
Migentra Egypt's industry is
Biotechnology Research
Migentra Egypt's top competitors are
Probiogen Ag,
Parkville,
Eipico,
Eva Pharma,
Migentra Gmbh,
Marcyrl Pharmaceutical Industries,
Minapharm Pharmaceuticals,
Hikma Pharmaceuticals,
Bgp,
Global Napi Pharmaceuticals.
Migentra Egypt's categories are Biotechnology Research
